+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07898033

Comparing 1-Year Recurrence After Modified En Bloc Resection ERBT Versus Transurethral Resection TURBT for Large Bladder Tumors Larger Than 2.5 cm

Led by dmitry enikeev · Updated on 2026-10-27

136

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing the pathological and cancer-related outcomes of two surgical methods Transurethral En Bloc Resection of Bladder Tumor ERBT and Transurethral Resection of Bladder Tumor TURBT in patients with large bladder tumors larger than 2.5 cm. This phase 3 trial aims to evaluate the recurrence rates after one year for these two procedures in treating non-muscle invasive bladder cancer NMIBC and transitional cell carcinoma TCC. The study is randomized and conducted without masking. Participants are assigned to one of two groups those undergoing ERBT surgery, which involves removing the bladder tumor in one piece using any energy source, and those receiving the standard TURBT surgery using mono or bipolar electrocautery. The primary outcome is the recurrence of bladder tumors at 12 months. Secondary outcomes include the presence of detrusor muscle during surgery, diagnosis of muscle-invasive cancer based on pathology, surgical complications within 30 days, and any conversion to a different surgical technique during the procedure. During the study, participants will be monitored perioperatively and followed for one year to assess tumor recurrence and other outcomes. Researchers will collect data on surgical results, pathology findings, and any complications. The trials total duration for each participant includes the surgery and a follow-up period of 12 months to evaluate the primary endpoint of recurrence and other safety and diagnostic measures.

CONDITIONS

Brief Title

1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder Tumors

Research Team

A

Avishay Reuven Shem Tov Dlugy, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here